de Lacerda Eduardo Braga Cavalcanti sold $434k of ABEV
See Remarks at AMBEV S.A.. 152,386 shares at an average of $2.85, traded Mar 27, 2026, filed Apr 13, 2026.
Score components
- +15RoleOfficer
- +17Trade size$434k at market
- +10Share of holdings soldSold 41% of holdings
- +8Cluster2 insiders selling within 14 days
What happened after comparable sells
Same side and tier, against the S&P 500, at 1, 3 and 6 months. Shown to Pro users; the whole table is on the backtest page.
This signal so far: 1m -0.3%, 3m -2.9%, 6m +1.7%.
Price around the trade, and since
From a quarter before the trade to today. The arrow is the trade, the circle the day the filing reached EDGAR, which is the first day anyone outside could act; the dotted line is the S&P 500 rebased to that day's close.
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value; the dashed line is the close on the filing day, the dotted line SPY rebased to it.Charts by TradingView Lightweight Charts™
Rows in this filing
Every transaction in Form 4 0001193125-26-153155, as filed. Open on EDGAR
| Date | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|
| Mar 27, 2026 | SOpen-market sale Common Shares | -152,386 | $2.85 | $434k | 223,340 | Apr 13, 2026 |
Related signals
Other insiders at AMBEV S.A. and this insider’s other filings.
| Score | Company | Insider | Value | Holdings | Filed |
|---|---|---|---|---|---|
| Pro nowfree Oct 15, 2026 | ABEVsell AMBEV S.A. | Prado Carla Smith de Vasconcellos Crippa See Remarks | $188k 60,757 shares | -43% | |
| 45Moderate | ABEVsell AMBEV S.A. | Ricardo Manuel Frangatos Pires Moreira director | $1.4M 468,040 shares | -13% | |
| 42Moderate | ABEVsell AMBEV S.A. | Paulo Andre Zagman See Remarks | $465k 136,250 shares | -37% | |
| 40Moderate | AMBEV S.A. | Parente Guilherme Malik See Remarks | $58k 20,971 shares | -44% |
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.